Influence of pre-treatment blood pressure levels on antihypertensive drug benefits in diabetics: the roadmap experience.

Conclusion: Blood pressure control is feasible in patients with diabetes without nephropathy, independent of baseline BP values. Asymmetric BP-lowering in the first year after starting therapy represents a true antihypertensive effect with sustainable shifts in BP severity. PMID: 32279529 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32279529?dopt=Abstract

Source: Blood Pressure - April 15, 2020 Category: Hematology Tags: Blood Press Source Type: research